Breast Specialists

Douglas W. Arthur, MD

Professor and Vice-chairman, 
Department of Radiation Oncology
VCU Medical Center/Massey Cancer Center 


Dr. Arthur's Interests include brachytherapy, management of breast malignancies and soft tissue malignancies.
More than 4,000 patients from across the U.S. will participate in the NSABP B-39 clinical trial. It was designed by Massey's Douglas W. Arthur, M.D., in collaboration with surgeons and radiation oncology investigators from around the country, and compares the effectiveness of whole breast irradiation to partial breast irradiation in women with stage 0, I or II breast cancer who have undergone lumpectomies




Jennifer Bellon, MD 

Associate Professor of Radiation Oncology
Director, Breast Radiation Oncology
Harvard Medical School 

Dr. Jennifer Bellon’s research interests predominantly focus on breast cancer, and in particular the integration of systemic therapy and radiation therapy. This includes both the optimal sequencing of the modalities, as well as the toxicities of combining radiation with novel chemotherapeutic agents. In addition, her work has focused on minimizing the toxicity of radiation therapy by shielding the heart during treatment, improving patient set-up during radiation therapy, and minimizing the volume of normal tissue with partial breast irradiation.




Bruce Haffty, MD

Chairman of the Department of Radiation Oncology 
University of Medicine & Dentistry of New Jersey
Robert Wood Johnson Medical School 
The Cancer Center Institute of New Jersey


Dr. Hafftyʼs interests include breast cancer, head cancer, and neck cancer. His specialty is Radiation Oncology.

GRANTS -

  • Impact of a common MDM2 SNP on the sensitivity to breast cancer treatment (DOD)
  • Significance of SNP309 in early onset breast cancer (CINJ Breast Cancer Research Grant )
  • Evaluation of the p53 binding protein 53BP1 in the local-regional management of breast cancer (Breast Cancer Research Foundation)





Jay Harris, MD

Professor, Department of Radiation Oncology, Harvard Medical School 
Chief, Radiation Oncology Department, Dana-Farber Cancer Institute 


Dr. Harris is Professor and Chair of the Department of Radiation Oncology at the Dana-Farber Cancer Institute and the Brigham and Women’s Hospital at Harvard Medical School. He also serves as Residency Program Director for the Harvard Radiation Oncology Program. He graduated from the Stanford University School of Medicine and did his residency at the Joint Center for Radiation Therapy at Harvard Medical School.  Dr. Harris’ main research interest has been in the area of breast cancer, with a focus on establishing the most effective and safe radiation treatment for these patients. He helped pioneer the use of breast-conserving therapy for patients with early stage breast cancer. Dr. Harris has been an active member of several professional medical societies, including ASTRO where he served as President and Chairman of the Board of Directors and the American Board of Radiology where he served as Trustee. Dr. Harris has written six books and currently sits on four editorial boards in the oncology field. He is the senior editor of Diseases of the Breast, now in its Fourth Edition. 


Abram Recht, MD

Professor of Radiation Oncology, Harvard Medical School
Deputy Chief, Department of Radiation Oncology, Beth Israel Deaconess Medical Center 

Dr. Recht’s clinical interests include breast cancer, gastrointestinal cancers, and gynecologic cancers. He has written, edited, or been co-author of more than 200 publications on all aspects of the local-regional therapy of breast cancer. He is currently co-chair of the Dana-Farber/Harvard Cancer Center breast cancer clinical research committee. He has served on breast-cancer related panels and committees of the American Joint Committeee on Cancer, the American College of Radiology, the American Society of Clinical Oncology (co-chairing its panel on the use of postmastectomy radiotherapy), the Eastern Cooperative Oncology Group, the European Organization for Research in Treatment of Cancer (most recently as American co-chair of its consensus meetings on ductal carcinoma in situ), and the Integration Panel of the Breast Cancer Research Program of the US Department of Defense. He has been listed in numerous compilations of “best doctors” in the United States.



Alphonse G. Taghian, MD, PhD

Professor, Harvard Medical School 
Chief, Breast Service, Department of Radiation Oncology, Massachusetts General Hospital


Dr. Alphonse Taghian gained his medical degree from Alexandria University in Egypt.  He did his residency in Radiation Oncology in France (Alexis Vautrin Cancer Center, Gustave Roussy Institute).  He obtained his PhD in Radiobiology from Paris XI University.  He is the chief of Breast Radiation Oncology at Massachusetts General Hospital and an Associate Professor of Radiation Oncology at Harvard Medical School.  Dr. Taghian has published more than 140 peer reviewed articles, general reviews and chapters.  He has edited a book on the multidisciplinary approach in the treatment of breast cancer.  He has been awarded several NIH grants for research totaling $2.2 Million for research in lymphedema.  He is internationally recognized as a leader in breast radiation oncology, the field of Accelerated Partial Breast Irradiation.  His other interests include, cardiac exposure to radiation, post-mastectomy radiation and early intervention for lymphedema.


Julia R. White, MD

Professor
Director, Breast Radiation Oncology
Vice Chair, Clinical Research
Department of Radiation Oncology
The Ohio State University Comprehensive Cancer Center
Arthur G. James Cancer Hosptial and Richard J. Solove Research Institute

 

Dr. White is involved in the development, execution, analysis, and oversight of clinical trials for breast cancer patients both within her own institution and nationally. She is currently the Chair of the Radiation Therapy Oncology Group (RTOG) Breast Cancer Committee and principal investigator for RTOG on a Phase III national clinical trial (NSABP B39 / RTOG 0413) enrolling 4300 early stage breast cancer patients. Her research focuses on the development and implementation of novel radiation regimens for breast cancer patients. This has lead to her involvement in developing and authoring multiple consensus statements on the use of radiation therapy for breast cancer treatment.





Benjamin D. Smith, MD 

Associate Professor of Radiation Oncology 
University of Texas MD Anderson Cancer Center 


Dr. Smith is an Associate Professor of Radiation Oncology at MD Anderson and a board-certified radiation oncologist with clinical and research expertise in cancer treatment and health services research. He is currently vice-chair of the American Society of Radiation Oncology guidelines subcommittee and has led ASTRO's efforts to develop evidence-based guidelines on accelerated partial breast radiation and fractionation of whole breast irradiation. He has authored or co-authored 37 peer reviewed original research papers. In addition, Dr. Smith maintains a busy portfolio of heath services research projects which broadly focus on leveraging existing health claims datasets to elucidate the use, effectiveness, toxicity, and cost-effectiveness of various radiation modalities commonly used in the treatment of cancer. As a radiation oncologist, Dr. Smith specializes in the care of women with breast cancer, and has a particular clinical interest in the care of elderly women with the disease. 




Meena S. Moran, MD
Associate Professor of Radiation Oncology
Yale University School of Medicine

Her primary focus of clinical research has been on clinical, pathological and molecular factors which may predict outcomes in breast cancer patients treated with radiation therapy, ethnic variations in breast cancer, and quality improvement in breast health care delivery.  She has been on the board of directors of the National Accreditation Program for Breast Centers (NAPBC) of the American College of Surgeons for the last 5 years, and she has worked to develop national guidelines, standards and a surveying process for accreditation of breast centers.  Dr. Moran has also been interested in investigating radiation techniques.  She is on the editorial board for the Journal of Clinical Oncology and The Breast Journal, and is an Associate Senior Breast Editor for International Journal of Radiation Therapy, Biology, Physics.  She is a member of the American College of Radiology Breast Appropriateness Criteria Committee to established clinical guidelines for breast cancer treatment.